Efficacy of 1-year treatment of risedronian in postmenopausal women in conection with polymorphism of OPG gene

Wanda Horst-Sikorska; Anna Wawrzyniak; Liliana Celczyńska-Bajew; Michalina Marcinkowska; Ryszard Słomski; Robert Kalak

eISSN: 2084-9834
ISSN: 0034-6233

Reumatologia/Rheumatology

Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

1/2005
vol. 43

Send email

Copy url:

abstract:

Efficacy of 1-year treatment of risedronian in postmenopausal women in conection with polymorphism of OPG gene

Wanda Horst-Sikorska

,

Anna Wawrzyniak

,

Liliana Celczyńska-Bajew

,

Michalina Marcinkowska

,

Ryszard Słomski

,

Robert Kalak

Reumatologia 2005; 43, 1: 12–16

Online publish date: 2005/03/14

View full text Get citation

Efficacy of risedronian in osteoporosis therapy in connection with polymorphism of osteoprotegerin gene (OPG) was observed in our study. We assessed 49 women with postmenopausal osteoporosis on basis of measurment of femoral neck bone density before treatment of risedronian and after 12 months of therapy. Our study population used calcium and vit. D therapy as well. Efficacy of osteoporosis treatment was assessed as presence or lack of bone fractures. Investigation of polymorphism of OPG gene in exon 1 was provided with PCR, SSCP. Other polymorphisms were genotyped by RFLP. On the basis of genetic investigation our study population wad divided on 3 groups: group with CC-allele, CG-allele, GG-allele. After one year observation of risedronian therapy we noticed the highest increase of bone density only in CG- allele group and the smallest increase in CC-allele group. During our study bone fractures was observed in 2 patients – 1 from CG-allele group, 1 from GG-allele group. In our study no statistically significance of risedronian therapy in connection with polymorphism of OPG gene in postmenopausal osteoporosis was found.

keywords:

risedronian, osteoporosis, osteoprotegerin gene

EVENTS/KONFERENCJE

BOOKS/KSIĄŻKI

Efficacy of 1-year treatment of risedronian in postmenopausal women in conection with polymorphism of OPG gene

Wanda Horst-Sikorska , Anna Wawrzyniak , Liliana Celczyńska-Bajew , Michalina Marcinkowska , Ryszard Słomski , Robert Kalak

risedronian, osteoporosis, osteoprotegerin gene

Wanda Horst-Sikorska

,

Anna Wawrzyniak

,

Liliana Celczyńska-Bajew

,

Michalina Marcinkowska

,

Ryszard Słomski

,

Robert Kalak